Daily Dose - Apr 18th, 2024
 
 
Daily Dose | View online
 
April 18, 2024
The CNBC 2024 Changemakers list highlighted fifty women as transformative leaders, including five from the pharma industry
The drugmaker shared positive late-stage trial results for its D1/D5 receptor in Parkinson’s disease, on the heels of its $8.7 billion buyout.
The oncology biotech could receive $1.2 billion in milestone payments and royalties on future sales.
Sponsored
Discover how Blue Mountain's Regulatory Asset Manager (RAM) propelled AmplifyBio, a leading Contract Research Organization (CRO), into a paperless future.